RecruitingPhase 2NCT05554393Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)Sponsor: National Cancer Institute (NCI)Portland, ME · Scarborough, ME · South Portland, ME · +172 more sites
RecruitingPhase 2NCT06317649Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)Sponsor: National Cancer Institute (NCI)Brunswick, ME · Portland, ME · +222 more sites
RecruitingPhase 2NCT06672146Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)Sponsor: National Cancer Institute (NCI)Brunswick, ME · Portland, ME · +132 more sites
RecruitingPhase not listedNCT04968834Genomically Profiling, Collecting, Archiving and Distributing Hematologic Malignancy SpecimensSponsor: Dana-Farber Cancer InstitutePortland, ME · +7 more sites